Actio Biosciences is a precision medicine company focused on developing life-changing treatments that target shared biology between rare and common diseases. By leveraging advances in genetics and drug discovery, they aim to enhance the probability of clinical success by starting with rare diseases, where they can pinpoint specific genetic targets. This unique approach not only addresses high unmet needs in rare diseases but also guides therapeutic expansion into more prevalent conditions, positioning Actio as a leader in genetics-led drug development.